One-Year Renal and Cardiac Effects of Bisoprolol versus Losartan in Recently Diagnosed Hypertensive Patients

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical drug investigation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/11315250-000000000-00000PMID 19663521
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are we misunderstanding beta-blockers.

  2007cited by this paper
• Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension

  2007cited by this paper
• Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms.

  2006cited by this paper
• Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes

  2006cited by this paper
• Beta blockers in the management of chronic kidney disease.

  2006cited by this paper
• Effects of ACE Inhibition and Angiotensin II Receptor Blockade on Glomerular Basement Membrane Protein Excretion and Charge Selectivity in Type 2 Diabetic Patients

  2006cited by this paper
• Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril, as Compared With the Opposite Sequence: Results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III

  2005cited by this paper
• The selectivity of β‐adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors

  2005cited by this paper
• The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

  2005cited by this paper
• Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.

  2005cited by this paper
• Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent

  2004cited by this paper
• Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.

  2003cited by this paper
• 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

  2003cited by this paper
• Comparison of the New Cardioselective Beta-Blocker Nebivolol with Bisoprolol in Hypertension: The Nebivolol, Bisoprolol Multicenter Study (NEBIS)

  2003cited by this paper
• What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?

  2003cited by this paper
• Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.

  2003cited by this paper
• Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.

  2001cited by this paper
• Effect of Long-Term Losartan Administration on Renal Haemodynamics and Function in Hypertensive Patients

  2000cited by this paper
• Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.

  1999cited by this paper
• β-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects

  1999cited by this paper
• Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.

  1999cited by this paper
• Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.

  1998cited by this paper
• Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.

  1998cited by this paper
• Vascular and glomerular expression of endothelin-1 in normal human kidney.

  1998cited by this paper
• Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.

  1998cited by this paper
• Vascular and glomerular expression of endothelin-1 in normal human kidney.

  1998cited by this paper
• Resetting of renal blood autoregulation during acute blood pressure reduction in hypertensive rats.

  1998cited by this paper
• Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide.

  1995cited by this paper
• Bisoprolol: Is This Just Another Beta-Blocker for Hypertension or Angina?

  1995cited by this paper
• Vasoconstrictors and renal protection induced by beta 1-selective adrenoceptor antagonist bisoprolol.

  1994cited by this paper
• Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation.

  1993cited by this paper
• Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients

  1993cited by this paper
• Systemic and Renal Hemodynamic Responses to Carvedilol and Metoprolol in Hypertensive Renal Transplant Patients

  1993cited by this paper
• Bisoprolol and Atenolol in Essential Hypertension: Effects on Systemic and Renal Hemodynamics and on Ambulatory Blood Pressure

  1993cited by this paper
• Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension.

  1993cited by this paper
• Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.

  1993cited by this paper
• Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: Randomized controlled trial versus hydrochlorothiazide

  1992cited by this paper
• Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis.

  1992cited by this paper
• [The effect of a single dose of Bisoprolol on changes in blood pressure and hemodynamic indicators in patients with mild hypertension].

  1992cited by this paper
• Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.

  1992cited by this paper
• Transesophageal echocardiography.

  1989cited by this paper
• Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

  1989cited by this paper
• Progression of renal insufficiency: role of blood pressure.

  1989cited by this paper
• 120 Does an adequate control of blood pressure protect the kidney in essential hypertension?

  1988cited by this paper
• Does an adequate control of blood pressure protect the kidney in essential hypertension

  1988cited by this paper
• Resetting of renal blood flow autoregulation in spontaneously hypertensive rats.

  1987cited by this paper
• Effect of antihypertensive treatment on kidney function in diabetic nephropathy.

  1987cited by this paper
• Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension.

  1986cited by this paper
• Nephron adaptation to renal injury or ablation.

  1985cited by this paper
• Renal and systemic hemodynamics in sustained essential hypertension.

  1984cited by this paper
• Association between blood pressure and the rate of decline in renal function with age.

  1984cited by this paper
• Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous).

  1982cited by this paper
• Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.

  1980cited by this paper
• Atenolol and three nonselective β‐blockers in hypertension

  1979cited by this paper
• Atenolol and three nonselective beta-blockers in hypertension.

  1979cited by this paper
• Individual renal plasma flow determination in 2 minutes.

  1976cited by this paper
• Letter: Effect of beta-blockade in chronic renal failure.

  1976cited by this paper
• Hypertension as a presenting feature of renal tuberculosis.

  1974cited by this paper
• Letter: Beta-blockade in the presence of renal disease and hypertension.

  1974cited by this paper
• Deterioration in Renal Function after Beta-blockade in Patients with Chronic Renal Failure and Hypertension

  1974cited by this paper
• Free Thyroxine Index

  1970cited by this paper

• Mathematical modeling of antihypertensive therapy

  2022cites this paper
• Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study

  2021cites this paper
• Thoroughly Calibrated Modular Agent-Based Model of the Human Cardiovascular and Renal Systems for Blood Pressure Regulation in Health and Disease

  2021cites this paper
• Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension

  2021cites this paper
• Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

  2021cites this paper
• COVID-19: a patient with cardiovascular disease at high risk

  2020cites this paper
• First-line renin–angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus

  2018cites this paper
• First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.

  2018cites this paper
• Renal function monitoring in heart failure – what is the optimal frequency? A narrative review

  2017cites this paper
• The Role of Beta-Blockers in the Treatment of Hypertension.

  2016cites this paper
• How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure

  2016cites this paper
• First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.

  2015cites this paper
• The Unholy Alliance between Obesity, Type-2 Diabetes, the Sympathetic Nervous System, and Hypertension in Young/Middle-Aged Subjects

  2014cites this paper
• Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implications.

  2014cites this paper
• Losartan ameliorates renal injury, hypertension, and adipocytokine imbalance in 5/6 nephrectomized rats.

  2013cites this paper
• [Bisoprolol: opportunities in the treatment of hypertension].

  2012cites this paper